By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sorrento Therapeutics, Inc. 

San Diego  California    U.S.A.
Phone: n/a Fax: n/a



Company News
Sorrento Therapeutics, Inc. And Conkwest Announce Exclusive Global Collaboration 12/19/2014 7:44:44 AM
Biotech Billionaire Bets $20 Million On Sorrento Therapeutics, Inc. 12/15/2014 7:50:07 AM
Sorrento Therapeutics, Inc. Announces Poster Presentations On Its Anti-C-Met/PD-L1 Bispecific Antibodies And Anti-C-Met-Antibody Drug Conjugate At The 37th Annual San Antonio Breast Cancer Symposium 12/8/2014 9:11:05 AM
Sorrento Therapeutics, Inc. To Present At The 2014 Oppenheimer Healthcare Conference 12/5/2014 12:46:14 PM
Sorrento Therapeutics, Inc. To Present At The 2014 Stifel Healthcare Conference 11/12/2014 9:32:36 AM
Sorrento Therapeutics, Inc. Release: Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel 10/15/2014 8:03:07 AM
Week In Review: Lee's Pharmaceutical Pays $50 Million For Novel Cancer Drug From Sorrento Therapeutics, Inc. 10/13/2014 9:36:00 AM
Sorrento Therapeutics, Inc., Lee's Pharma Forge $49.6 Million Pact 10/6/2014 8:24:33 AM
Sorrento Therapeutics, Inc. To Present At Two Healthcare Conferences 9/5/2014 12:17:20 PM
Sorrento Therapeutics, Inc. Awarded National Institutes of Health (NIH) Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 8/26/2014 9:25:40 AM